Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 11/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.51 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | RORC | P51449 | 2/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20186980 | 0.81 | SLC22A12 (0.54) | FFAR4ARRORC | |
| SCHEMBL20186985 | 0.81 | AR (0.48) | FFAR4ARRORC | |
| SCHEMBL28543669 | 0.80 | FFAR4 (1.00) | FFAR4FFAR1KMT2A | |
| SCHEMBL20186977 | 0.80 | NPC1 (0.49) | FFAR4ARKMT2A | |
| SCHEMBL20186974 | 0.80 | KMT2A (0.43) | FFAR4ARKMT2ARORC | |
| SCHEMBL20186983 | 0.75 | FFAR4 (0.39) | FFAR4KMT2ARORC | |
| SCHEMBL28537715 | 0.74 | FFAR4 (1.00) | FFAR4FFAR1KMT2A | |
| SCHEMBL20186995 | 0.74 | SLC22A12 (0.54) | FFAR4ARRORC | |
| SCHEMBL20186962 | 0.74 | AR (0.42) | FFAR4ARRORCKIF11 | |
| SCHEMBL28534522 | 0.70 | FFAR4 (0.67) | FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10905120-B2 | ABA receptor agonists that modulate transpiration | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-02 | — | — | US | disclosed |
| US-20180146666-A1 | ABA RECEPTOR AGONISTS THAT MODULATE TRANSPIRATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10905120-B2 | ABA receptor agonists that modulate transpiration | ADORA2A, ADORA1, AAK1 | FFAR4 47/4885FFAR1 13/4885AR 1334/4885 |
| US-20180146666-A1 | ABA RECEPTOR AGONISTS THAT MODULATE TRANSPIRATION | ADORA2A, ADORA1, AAK1 | FFAR4 47/4885FFAR1 13/4885AR 1334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.